JLJean-Philippe Lucot

Jean-Philippe Lucot

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jean-Philippe Lucot has a total of 73 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Do Surgeons Anticipate Women’s Hopes and Fears Associated with Prolapse Repair? A Qualitative Analysis in the PROSPERE Trial

    by Xavier Fritel, Marion Ravit, Anne-Cécile Pizzoferrato, Sandrine Campagne-Loiseau, Georges Bader, Perrine Capmas, Michel Cosson, Philippe Debodinance, Xavier Deffieux, Hervé Fernandez, et al.

    Women’s preoperative perceptions of pelvic-floor disorders may differ from those of their physicians. Our objective was to specify women’s hopes and fears before cystocele repair, and to compare them to those that surgeons anticipate. We performed a secondary qualitative analysis of data from the PROSPERE trial. Among the 265 women included, 98% reported at least one hope and 86% one fear before surgery. Sixteen surgeons also completed the free expectations-questionnaire as a typical patient would. Women’s hopes covered seven themes, and women’s fears eleven. Women’s hopes were concerning prolapse repair (60%), improvement of urinary function (39%), capacity for physical activities (28%), sexual function (27%), well-being (25%), and end of pain or heaviness (19%). Women’s fears were concerning prolapse relapse (38%), perioperative concerns (28%), urinary disorders (26%), pain (19%), sexual problems (10%), and physical impairment (6%). Surgeons anticipated typical hopes and fears which were very similar to those the majority of women reported. However, only 60% of the women reported prolapse repair as an expectation. Women’s expectations appear reasonable and consistent with the scientific literature on the improvement and the risk of relapse or complication related to cystocele repair. Our analysis encourages surgeons to consider individual woman’s expectations before pelvic-floor repair.

  • Open Access

    Serious Complications and Recurrence following Sacrospinous Ligament Fixation for the Correction of Apical Prolapse

    by Susie De Gracia, Brigitte Fatton, Michel Cosson, Sandrine Campagne-Loiseau, Philippe Ferry, Jean-Philippe Lucot, Philippe Debodinance, Laure Panel, Xavier Deffieux, Olivier Garbin, et al.

    Objective: To evaluate the rates of serious complications and reoperation for recurrence following sacrospinous ligament fixation (SSLF) for apical pelvic organ prolapse. Methods: This was a national registry ancillary cohort comparative study. The VIGI-MESH registry includes data from 24 French health centers prospectively collected between May 2017 and September 2021. Time to occurrence of a serious complication or reoperation for genital prolapse recurrence was explored using the Kaplan–Meier curve and Log-rank test. The inverse probability of treatment weighting, based on propensity scores, was used to adjust for between-group differences. Results: A total of 1359 women were included and four surgical groups were analyzed: Anterior SSLF with mesh (n = 566), Anterior SSLF with native tissue (n = 331), Posterior SSLF with mesh (n = 57), and Posterior SSLF with native tissue (n = 405). Clavien–Dindo Grade III complications or higher were reported in 34 (2.5%) cases, with no statistically significant differences between the groups. Pelvic organ prolapse recurrence requiring re-operation was reported in 44 (3.2%) women, this was higher following posterior compared with anterior SSLF (p = 0.0034). Conclusions: According to this large database ancillary study, sacrospinous ligament fixation is an effective and safe surgical treatment for apical prolapse. The different surgical approaches (anterior/posterior and with/without mesh) have comparable safety profiles. However, the anterior approach and the use of mesh were associated with a lower risk of reoperation for recurrence compared with the posterior approach and the use of native tissue, respectively.


  • Long‐term outcomes of primary cystocele repair by transvaginal mesh surgery versus laparoscopic mesh sacropexy: extended follow up of the PROSPERE multicentre randomised trial

    by Jean-Philippe Lucot, Michel Cosson, Stephane Verdun, Philippe Debodinance, Georges Bader, Sandrine Campagne-Loiseau, Delphine Salet-Lizee, Cherif Akladios, Philippe Ferry, Renaud De Tayrac, et al.

    Objective To compare the effectiveness and safety of Laparoscopic Sacropexy (LS) and Transvaginal mesh (TVM) at four years. Design Extended follow-up of a randomised trial. Setting 11 centres Population Women with cystocele stage ≥ 2 (POP-Q), aged 45 to 75 years without previous prolapse surgery. Methods Synthetic non-absorbable mesh placed in the vesicovaginal space and sutured to the promontory (LS) or maintained by arms through pelvic ligaments and/or muscles (TVM). Main Outcome Measures Functional outcomes (PFDI-20 as primary outcome); anatomical assessment (POP-Q), composite outcome of success; reinterventions for complications. Results 220 out of 262 randomised patients have been followed at 4 years. PFDI-20 significantly improved in both groups and was better (but under the minimal clinically important difference) after LS (mean difference -7.2 points; 95% CI: -14.0 to -0.05; P = 0.029). The improvement in quality of life and the success rate (LS: 70%, 61% to 81% vs TVM: 71%, 62% to 81%; HR 0.92, 0.55 to 1.54; P = 0.75) were similar. POP-Q measurements did not differ, except for point C (LS -57 mm vs TVM -48 mm, P = 0.0093). The grade III or higher complication rate was lower after LS (2% (0% to 4.7%) vs TVM (8.7%, 3.4% to 13.7%; HR: 4.6, 1.007 to 21.0, P = 0.049)). Conclusions Both techniques provided improvement and similar success rates. LS had a better benefit/harm balance with fewer reinterventions due to complications. TVM remains an option when LS is not feasible.


  • Complications, revision and perceived health after surgery for stress urinary incontinence by mid urethra sling inthe VIGI-MESH register: Description and medium-term incidence for 1814 women

    by T. Charles, L. Wagner, S. Campagne-Loiseau, P. Ferry, C. Saussine, M. Cosson, X. Deffieux, M. Hummel, L. Panel, J.-P. Lucot, et al.

  • Open Access

    Association of Hysteroscopic vs Laparoscopic Sterilization With Procedural, Gynecological, and Medical Outcomes

    by Kim Bouillon, Marion Bertrand, Georges Bader, Jean-Philippe Lucot, Rosemary Dray-Spira, Mahmoud Zureik

    (Abstracted from JAMA 2018;319:375–387) The main types of female sterilization in developed countries are laparoscopic and hysteroscopic sterilization. Approximately 1 million women worldwide have undergone the hysteroscopic procedure.


  • A randomised comparison of single-incision versus traditional transobturator midurethral sling in women with stress urinary incontinence: results of a 24-month follow-up

    by René P. Schellart, Katrien Oude Rengerink, Frank Van der Aa, Jean-Philippe Lucot, Bart Kimpe, Marcel G. W. Dijkgraaf, Jan-Paul W. R. Roovers

    Introduction and hypothesis Midurethral sling procedures have become the principal surgical treatment for women with stress urinary incontinence (SUI). The 1-year results of this international trial comparing the efficacy and morbidity of a single-incision midurethral sling (SIMS; MiniArc) and a transobturator standard midurethral sling (SMUS; Monarc) showed that MiniArc is non-inferior regarding subjective cure and superior with regard to postoperative pain and recovery. The objective was to compare subjective and objective cure, morbidity and surgery-related discomfort following SIMS and transobturator SMUS up to a 24-month follow-up. Methods We carried out a non-blinded, randomised, controlled trial. Women with symptomatic SUI were eligible. Primary outcome was subjective cure, defined as an improvement on the Patient Global Impression of Improvement (PGI-I), at 12, 24 and 36 months. Secondary outcomes were objective cure based on the cough stress test, disease-specific quality of life questionnaires, surgical parameters and physical performance during recovery. Analysis was by intent to treat. Differences between the two groups regarding dichotomous variables were Chi-squared tested and presented as relative risks (RR) with corresponding 95 % confidence intervals. Results We randomised 97 women to MiniArc and 96 to Monarc. At the 24-month follow-up, subjective cure was 84 % following MiniArc and 89 % following Monarc (RR −5; 95% CI −0.17 to 0.06). Objective cure was 93 % following MiniArc and 94 % following Monarc (RR −1; 95% CI −0.10 to 0.07). Both procedures have low complication rates. Conclusions At the 2-year follow-up, the non-prespecified analysis of this randomised trial showed that the MiniArc, a single-incision sling, had similar subjective and similar objective cure rates, although non-inferiority to Monarc for subjective cure could not be demonstrated.


  • Cure de rectocèle par prothèse type Transvaginal Mesh et compression rectale: à propos de trois cas

    by V. Emmanuelli, C. Rubod, E. Poncelet, J.-P. Lucot, J.-F. Quinton, M. Cosson